key: cord-0744628-6qu6a44m
authors: Chamie, Gabriel; Marquez, Carina; Crawford, Emily; Peng, James; Petersen, Maya; Schwab, Daniel; Schwab, Joshua; Martinez, Jackie; Jones, Diane; Black, Douglas; Gandhi, Monica; Kerkhoff, Andrew D; Jain, Vivek; Sergi, Francesco; Jacobo, Jon; Rojas, Susana; Tulier-Laiwa, Valerie; Gallardo-Brown, Tracy; Appa, Ayesha; Chiu, Charles; Rodgers, Mary; Hackett, John; Kistler, Amy; Hao, Samantha; Kamm, Jack; Dynerman, David; Batson, Joshua; Greenhouse, Bryan; DeRisi, Joe; Havlir, Diane V
title: SARS-CoV-2 Community Transmission disproportionately affects Latinx population during Shelter-in-Place in San Francisco
date: 2020-08-21
journal: Clin Infect Dis
DOI: 10.1093/cid/ciaa1234
sha: 78ff160285f0d5393ab98ce26d55f398b38ac804
doc_id: 744628
cord_uid: 6qu6a44m

BACKGROUND: There is urgent need to understand the dynamics and risk factors driving ongoing SARS-CoV-2 transmission during shelter-in-place mandates. METHODS: We offered SARS-CoV-2 reverse transcription-PCR and antibody (Abbott ARCHITECT IgG) testing, regardless of symptoms, to all residents (≥4 years) and workers in a San Francisco census tract (population: 5,174) at outdoor, community-mobilized events over four days. We estimated SARS-CoV-2 point prevalence (PCR-positive) and cumulative incidence (antibody or PCR-positive) in the census tract and evaluated risk factors for recent (PCR-positive/antibody-negative) versus prior infection (antibody-positive/PCR-negative). SARS-CoV-2 genome recovery and phylogenetics were used to measure viral strain diversity, establish viral lineages present, and estimate number of introductions. RESULTS: We tested 3,953 persons: 40% Latinx; 41% White; 9% Asian/Pacific Islander; and 2% Black. Overall, 2.1% (83/3,871) tested PCR-positive: 95% were Latinx and 52% asymptomatic when tested. 1.7% of census tract residents and 6.0% of workers (non-census tract residents) were PCR-positive. Among 2,598 tract residents, estimated point prevalence of PCR-positives was 2.3% (95%CI: 1.2-3.8%): 3.9% (95%CI: 2.0-6.4%) among Latinx vs. 0.2% (95%CI: 0.0-0.4%) among non-Latinx persons. Estimated cumulative incidence among residents was 6.1% (95%CI: 4.0-8.6%). Prior infections were 67% Latinx, 16% White, and 17% other ethnicities. Among recent infections, 96% were Latinx. Risk factors for recent infection were Latinx ethnicity, inability to shelter-in-place and maintain income, frontline service work, unemployment, and household income &$50,000/year. Five SARS-CoV-2 phylogenetic lineages were detected. CONCLUSION: SARS-CoV-2 infections from diverse lineages continued circulating among low-income, Latinx persons unable to work from home and maintain income during San Francisco’s shelter-in-place ordinance.

In early 2020, multiple introductions of SARS-CoV-2 into the United States laid the foundation for the ongoing epidemic that has claimed over 100,000 U.S. lives in less than 6 months. [1] Some of the earliest clinical cases of COVID-19 were recognized in California, [2] and the state led the nation in issuing a state-wide shelter-in-place mandate on March 19. [3] San Francisco declared a local emergency on February 25 and issued a series of increasingly restrictive mandates on sizes of gatherings culminating in a shelter-in place order on March 16. Although peak hospitalization and death rates in San Francisco over the ensuing month were nearly 10-fold lower than hard-hit cities such as New York,[4] the pattern of disproportionately higher hospitalizations among Latinx communities was similar. [5] In San Francisco, 45% of reported COVID-19 cases are among Latinx people, who represent 15% of the city's population, and at San Francisco General Hospital, a large public hospital with a patient population that is 31% Latinx, 81% of COVID-19related hospitalizations from March-May 2020 were among Latinx people. [6, 7] Hospitalizations and deaths represent a small fraction of total SARS-CoV-2 infections. [8] [9] [10] Estimates of the burden of community SARS-CoV-2 infections from direct measurements have been difficult to obtain and compare because symptomatic testing programs capture only a proportion of cases, [11] the recognized symptoms associated with COVID-19 have expanded over time, [12] the assays used to identify infection have variable performance characteristics, and easily accessible testing programs are not in place for some of the most highly affected communities. Data on community transmission and ethnic disparities in SARS-CoV-2 infection, as opposed to COVID-19 disease [13] , as well as systematic efforts to determine factors driving these disparities remain limited. [14] To estimate the point prevalence and cumulative incidence of infection, determine risk factors for ongoing versus prior infection and characterize ongoing transmission and viral strain diversity with phylogenetic analyses, we offered population-based, universal PCR and antibody A c c e p t e d M a n u s c r i p t 7 testing for SARS-CoV-2 infection, regardless of symptoms, to all residents of a densely populated census tract within a majority Latinx community in San Francisco.

Unidos en Salud is a longitudinal study to characterize SARS-CoV-2 epidemiology and assess impact of public health measures within a US census tract in San Francisco. Six-weeks into the city's shelter-in-place ordinance, we provided cross-sectional, mass, low-barrier SARS-CoV-2 reverse transcription-PCR (RT-PCR) and antibody testing, regardless of symptoms, to residents (>4 years) and people who work but may not reside in the census tract. A c c e p t e d M a n u s c r i p t 8

From April 25-28, 2020, we offered outdoor testing at public parks and schools to those who provided an address in the census tract or worked in the tract. On April 28, we expanded eligibility to residents of neighboring city blocks (two blocks north, three blocks east and one block south), responding to high community demand. During pre-registration, we conducted a brief survey. At the time of testing, we obtained verbal consent for participation and conducted COVID-19 symptom screening. Medical staff performed a fingerstick blood collection (500µL) for antibody testing and an oropharyngeal/mid-turbinate nasal swab for quantitative RT-PCR. Participants could opt out of either test. We contacted all PCR-positive persons to disclose results and perform a clinical assessment. We provided household support via a community-led team for PCR-positive participants and evaluated symptoms among all PCR-positive participants over 2 weeks following testing.

Swabs were collected in DNA/RNA Shield (Zymo Research) to inactivate virus and preserve RNA stability. RT-PCR of viral N and E genes and human RNAse P gene was performed on extracted RNA at a CLIA-certified laboratory operated by UCSF and the Chan Zuckerberg Biohub using a Laboratory Developed Test with a limit of detection of log 10 4.5 viral genome copies/mL. SARS-CoV-2-positive RNA samples were subjected to Primal-Seq Nextera XT version 2.0, [16] Phylogenetics were used to measure strain diversity.

Proportions were compared using chi-squared tests and medians compared using Wilcoxon rank-sum tests. Cumulative incidence of infection was adjusted for RT-PCR and antibody test characteristics; 95% confidence intervals incorporating uncertainty in test characteristics were based on bootstrap. For census tract residents, we further adjusted for differences in age, sex, and race/ethnicity of participants compared to 2018 census estimates (Supplementary Methods). We used multivariate logistic regression for the dependent outcome of PCR-positivity among participants tested and included the independent variables sex, frontline worker status, household income and reporting a COVID-19 contact, based on a priori interest and univariate results. We did not adjust confidence intervals for multiple testing.

A phylogenetic tree was constructed containing all 123 SARS-CoV-2 genomes from San Francisco County on GISAID [19] on May 22, 2020 together with the high-quality consensus genomes assembled from this study, using the nextstrain toolkit. [20] Global clade identification and naming follows the Nextstrain proposal,[21] and significance of population structure was computed by a permutation test was used for Hudson's FST (Supplementary Methods). [22] A c c e p t e d M a n u s c r i p t 10

The UCSF Committee on Human Research determined that the study met criteria for public health surveillance.

The study was supported by the Chan Zuckerberg Biohub, UCSF, and a Program for Breakthrough Biomedical Research award. ARCHITECT SARS-CoV-2 test kits were provided by Abbott Laboratories. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Overall, 3,953 persons were tested during the campaign. Of all persons tested, 53% were male, and 40% identified as Latinx, 41% White, 9% Asian/Pacific Islander, 2% Black, and 7% other/mixed ethnicity ( Table 1) . A significantly higher proportion of Latinx compared to non-Latinx participants reported annual household income <$50,000/year (62% vs. 19%), living with >5 persons/household (25% vs. 5%) and working frontline service jobs (43% vs. 17%, Supplementary Table S1). Estimated census tract testing coverage of adult residents (age >20 years) was 60%. Among PCR-positive persons, 95% identified as Latinx, median age was 38 years (interquartile range [IQR]: 28-50 years), and 76% were male. Persons testing PCR-positive were significantly more likely than persons testing PCR-negative to identify as Latinx, report inability to shelter-in-place and maintain income, work frontline-service jobs or be unemployed, and live in households with income <$50,000/year and >3 persons/household ( Table 2 

Among 3,861 participants tested for SARS-CoV-2 antibodies, 3.4% (131) tested Ab-positive:

3.1% (80/2,545; 95%CI: 2.5%-3.9%) among census tract residents compared to 7.7% (34/442; 95%CI: 5.4%-10.6%) among tract workers and 2.1% (17/829; 95%CI: 1.2%-3.3%) among adjacent city block residents. Estimated cumulative incidence (Ab or PCR-positive) among tract residents was 4.4% (95% CI: 3.2%-5.6%) after adjusting for test characteristics and 6.1% (95%CI: 4.0%-8.6%) after further adjusting for participation (Supplementary Table S2) . result from infections that occurred, generated antibodies and resolved to PCR-negative over the six weeks following the shelter-in-place order. Fingerstick sampling could also impact antibody test performance. However, the EUA antibody test we used has been shown to have a high sensitivity (96.9-100%) at ≥17-22 days post symptom onset, and high specificity (≥99.6%) with venous drawn plasma,[32, 33] and our estimates of cumulative incidence accounted for sensitivity and specificity of A c c e p t e d M a n u s c r i p t 17 the PCR and antibody assays used. Second, selection bias in who chose to test may have affected our estimates. Although we adjusted for demographic differences between participants and community composition based on 2018 American Community Survey data, these data may not fully reflect tract demographics in 2020. However, population-based testing in a census tract allowed for greater clarity in understanding who did not participate. Lastly, we relied on self-reported symptoms and survey responses, which may have resulted in misclassification. With follow-up of PCR-positive participants over two weeks, we were able to further explore symptom status, allowing for monitoring and reclassification.

In conclusion, improving access to SARS-CoV-2 testing, regardless of symptoms, through community-led, low-barrier testing programs in vulnerable communities is feasible. Adding economic support and protections for low-income workers during isolation and quarantine could further increase testing and contribute to reducing community transmission and the massive disparities in SARS-CoV-2 infection observed in the U.S. M a n u s c r i p t 28 

Public Health Response to the Initiation and Spread of Pandemic COVID-19 in the United States

Transmission of COVID-19 to Health Care Personnel During Exposures to a Hospitalized Patient

Variation in COVID-19 Hospitalizations and Deaths Across New York City Boroughs

Estimates of the severity of coronavirus disease 2019: a model-based analysis. The Lancet infectious diseases 2020

COVID-19 Testing, Epidemic Features, Hospital Outcomes, and Household Prevalence

Asymptomatic Transmission, the Achilles' Heel of Current Strategies to Control Covid-19

Hospitalization and Mortality among Black Patients and White Patients with Covid-19

Racial Health Disparities and Covid-19 -Caution and Context. The New England journal of medicine

Multiplex PCR method for MinION and Illumina sequencing of Zika and other virus genomes directly from clinical samples

disease and diplomacy: GISAID's innovative contribution to global health

nextflu: real-time tracking of seasonal influenza virus evolution in humans

Estimation of levels of gene flow from DNA sequence data

Population Point Prevalence of SARS-CoV-2

Infection Based on a Statewide Random Sample -Indiana

A c c e p t e d M a n u s c r i p t 21